Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi medikasi
Panduan penyiapan dan pemberian terapi medikasi
Meropenem
Risiko Phlebitis sedang
Kejadian Kadang-kadang (1/100 – 1/1000 kejadian)
Disarankan pengawasan selama infus berlangsung.
Penyiapan
Sediaan
- 500 mg/vial
- 1 gram/vial
- 2 gram/vial
Rekomendasi Pengenceran (Konsentrasi)
20-100 mL
Pelarut
- D5%
- NaCl 0.9%
Pemberian
Rekomendasi Akses
IV
Rekomendasi Durasi Pemberian
pengenceran 20 mL durasi 3-4 jam
pengenceran 100 mL durasi 15-30 menit
pengenceran 100 mL durasi 15-30 menit
Stabilitas Obat Setelah Rekonstruksi
4 jam pada suhu 25 derajat celcius
22 jam pada suhu 2-8 derajat celcius
22 jam pada suhu 2-8 derajat celcius
Keamanan
pH
7,3-8,3
pH risiko sedang (4,0-5,0 / 7,5-9,0)
Osmolaritas Sebelum Pengenceran
356-417
Osmolaritas rendah (<600)
Phlebitis
Ya
Kadang-kadang (1/100 – 1/1000 kejadian)
Disarankan pengawasan selama infus berlangsung.
Disarankan pengawasan selama infus berlangsung.
Inkompatibilitas
-
Albumin Human
-
Amiodaron
-
Anidulafungin
-
Calcium Chloride
-
Calcium gluconate
-
Acyclovir sodium
-
Amphotericin B
-
Ciprofloxacin
-
Doxycycline hyclate
-
Mannitol
-
Multivitamins
-
Zidovudine
-
Pantoprazole sodium
-
Bupivacaine HCl
-
Ciprofloxacin
-
Diazepam
-
Dobutamine HCl
-
Lorazepam
-
Hydroxyzine HCl
-
Midazolam
-
Nitroglycerin
-
Ondansetron HCl
-
Phenytoin sodium
-
Sodium phosphates
-
Vancomycin HCl
- Zidovudine
Klasifikasi GHS
Irritant
Health Hazard
Manifestasi GHS
H315 (76.9%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (23.1%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H319 (76.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H334 (23.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H335 (76.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
H317 (23.1%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H319 (76.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H334 (23.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H335 (76.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Sumber
- American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850